Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
Emerson’s Michalle Adkins, Benjamin Arriola & Brandon Haschke are co-authors along with professionals in leading biopharmaceutical manufacturing and suppliers in the BioPhorum work, In-line monitoring / real-time release testing in biopharmaceutical processes – prioritization and cost benefit analysis.
Emerson’s Michalle Adkins alerted me to the release of a new BioPhorum Knowledge Management white paper, A Test Case in CMC Business Processes from Late-Stage Development to Commercial Manufacturing.
For biopharmaceutical producers, creating value from the knowledge capture and dissemination is paramount. At the upcoming February 23-26 IFPAC [International Foundation Process Analytical Chemistry] conference, Emerson’s Michalle Adkins will present on the impact of KM in product and process development for biopharmaceutical manufacturers.
Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
Emerson’s Michalle Adkins will be presenting, Update on BioPhorum’s Roadmap for In-line Monitoring and Real- Time Release at the conference.
At this past autumn’s Emerson Exchange conference in San Antonio, Texas, Emerson’s Michalle Adkins demonstrated single use manufacturing measurement and control devices and how they could be used to measure and control biomanufacturing operations in a single use environment.
In this 2:25 YouTube video, Address Cell Therapy Batch Production Challenges with Syncade, Emerson’s Michalle Adkins shares how operations management technology plays an important role in addressing these challenges.
Yesterday we highlighted advancements in exception management technology for pharmaceutical and biopharmaceutical manufacturers. Exception management is one element in an electronic batch record (EBR). Other elements for the EBR which also have high data integrity...
We seem to be fully in the swing of industry conferences. This week is the pharmaceutical and biotech manufacturing industries' INTERPHEX conference in New York City. It: …brings over 11,000 global industry professionals and 650+ leading suppliers together to "Learn...
Update: This post has been updated with a link to the most recent Medicines & Healthcare products Regulatory Agency (MHRA) ‘GXP’ Data Integrity Guidance and Definitions - March 2018 document. For pharmaceutical, biotech and other manufacturers in highly-regulated...
Many industries have benefitted from the use of wireless instrumentation, but how about the pharmaceutical and biotech manufacturing industries? Are there applications which might improve the performance of their operations? In a Pharmaceutical Manufacturing article,...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.